发文分析
近年国家/地区发文量统计
| 国家/地区 | 数量 |
|---|---|
| USA | 128 |
| England | 45 |
| France | 24 |
| GERMANY (FED REP GER) | 21 |
| Belgium | 17 |
| Netherlands | 17 |
| Australia | 16 |
| Switzerland | 16 |
| CHINA MAINLAND | 15 |
| Canada | 13 |
近年机构发文量统计
| 机构 | 数量 |
|---|---|
| UNIVERSITY OF TEXAS SYSTEM | 17 |
| UNIVERSITY OF OXFORD | 15 |
| GLAXOSMITHKLINE | 13 |
| UNIVERSITY OF LONDON | 12 |
| SANOFI-AVENTIS | 11 |
| UNIVERSITY OF CALIFORNIA SYSTEM | 10 |
| HARVARD UNIVERSITY | 9 |
| UNIVERSITY OF WASHINGTON | 9 |
| INFECT DIS RES INST | 8 |
| INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERC... | 8 |
近年文章引用他刊数据
| 文章名称 | 引用次数 |
|---|---|
| Turning the corner on therapeutic cancer vaccines | 77 |
| Optimizing the utilization of aluminum adjuvants in vacc... | 39 |
| Long-term reduction in hyperglycemia in advanced type 1 ... | 26 |
| Current status of Zika vaccine development: Zika vaccine... | 21 |
| The TLR-4 agonist adjuvant, GLA-SE, improves magnitude a... | 21 |
| From therapeutic antibodies to immune complex vaccines | 20 |
| Cell culture-derived influenza vaccines in the severe 20... | 19 |
| Recent advances in the production of recombinant glycoco... | 18 |
| LepVax, a defined subunit vaccine that provides effectiv... | 15 |
| A prophylactic alpha-Gal-based glycovaccine effectively ... | 14 |
近年被他刊引用数据
| 期刊名称 | 引用次数 |
|---|---|
| FRONT IMMUNOL | 42 |
| VACCINE | 30 |
| NPJ VACCINES | 27 |
| VACCINES-BASEL | 23 |
| EXPERT REV VACCINES | 18 |
| VIRUSES-BASEL | 16 |
| SCI REP-UK | 13 |
| HUM VACC IMMUNOTHER | 11 |
| J INFECT DIS | 10 |
| J VIROL | 9 |